Susan Whichard

Director/Board Member at Neuromod Devices Ltd.

Health Technology

Profile

Susan Whichard is currently a Non-Executive Director at Neuromod Devices Ltd.
She previously worked as Vice President-Consumer & Professional Services at InSound Medical, Inc. in 2011.

Susan Whichard active positions

Companies	Position	Start
Neuromod Devices Ltd. Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland.	Director/Board Member	15/08/2021

All active positions of Susan Whichard

Former positions of Susan Whichard

Companies	Position	End
InSound Medical, Inc. InSound Medical, Inc. Medical SpecialtiesHealth Technology InSound Medical, Inc. developed and manufactured hearing devices. The company was founded in 1998 and was headquartered in Newark, CA.	Corporate Officer/Principal	19/10/2011

See the detail of Susan Whichard's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Susan Whichard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
InSound Medical, Inc. InSound Medical, Inc. Medical SpecialtiesHealth Technology InSound Medical, Inc. developed and manufactured hearing devices. The company was founded in 1998 and was headquartered in Newark, CA.	Health Technology
Neuromod Devices Ltd. Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland.	Health Technology